# Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment

> **NCT00466609** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 54 (actual)

## Conditions studied

- Obsessive Compulsive Disorder

## Interventions

- **DRUG:** Clomipramine (fluoxetine plus clomipramine)
- **DRUG:** Quetiapine (fluoxetine plus quetiapine)
- **DRUG:** Placebo (fluoxetine plus placebo)

## Key facts

- **NCT ID:** NCT00466609
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-04
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2017-10-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466609, "Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00466609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*